SEARCH

SEARCH BY CITATION

References

  • 1
    Mun, E. C., Blackburn, G. L., Matthews, JB. (2001) Current status of medical and surgical therapy for obesity. Gastroenterology. 120: 669681.
  • 2
    Cummings, D. E., Weigle, D. S., Frayo, R. S., et al (2002) Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med. 346: 16231630.
  • 3
    Tritos, N. A., Mun, E., Bertkau, A., Grayson, R., Maratos-Flier, E., Goldfine, A. (2003) Serum ghrelin levels in response to glucose load in obese subjects post-gastric bypass surgery. Obes Res. 11: 919924.
  • 4
    Batterham, R. L., Cowley, M. A., Small, C. J., et al (2002) Gut hormone PYY(3–36) physiologically inhibits food intake. Nature. 418: 650654.
  • 5
    Challis, B. G., Pinnock, S. B., Coll, A. P., Carter, R. N., Dickson, S. L., O'Rahilly, S. (2003) Acute effects of PYY3–36 on food intake and hypothalamic neuropeptide expression in the mouse. Biochem Biophys Res Commun. 311: 915919.
  • 6
    Batterham, R. L., Cohen, M. A., Ellis, S. M., et al (2003) Inhibition of food intake in obese subjects by peptide YY3–36. N Engl J Med. 349: 941948.
  • 7
    Tschop, M., Castaneda, T. R., Joost, H. G., et al (2004) Physiology: does gut hormone PYY3–36 decrease food intake in rodents? Nature. 430: 1
  • 8
    Korner, J., Bessler, M., Cirilo, L. J., et al (2005) Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin. J Clin Endocrinol Metab. 90: 359365.
  • 9
    Adrian, T. E., Ferri, G. L., Bacarese-Hamilton, A. J., Fuessl, H. S., Polak, J. M., Bloom, SR. (1985) Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology. 89: 10701077.
  • 10
    Considine, R. V., Sinha, M. K., Heiman, M. L., et al (1996) Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med. 334: 292295.
  • 11
    Heymsfield, S. B., Greenberg, A. S., Fujioka, K., et al (1999) Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial. JAMA. 282: 15681575.
  • 12
    Strader, A. D., Vahl, T. P., Jandacek, R. J., Woods, S. C., D'Alessio, D. A., Seeley, RJ. (2005) Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in rats. Am J Physiol Endocrinol Metab. 288: E447E453.
  • 13
    Moriarty, P., Dimaline, R., Thompson, D. G., Dockray, GJ. (1997) Characterization of cholecystokininA and cholecystokininB receptors expressed by vagal afferent neurons. Neuroscience. 79: 905913.
  • 14
    Alvarez, B. M., Borque, M., Martinez-Sarmiento, J., et al (2002) Peptide YY secretion in morbidly obese patients before and after vertical banded gastroplasty. Obes Surg. 12: 324327.
  • 15
    Stoeckli, R., Chanda, R., Langer, I., Keller, U. (2004) Changes of body weight and plasma ghrelin levels after gastric banding and gastric bypass. Obes Res. 12: 346350.
  • 16
    Leonetti, F., Silecchia, G., Iacobellis, G., et al (2003) Different plasma ghrelin levels after laparoscopic gastric bypass and adjustable gastric banding in morbid obese subjects. J Clin Endocrinol Metab. 88: 42274231.